Home » Newsletters » BioWorld Science

BioWorld Science

June 14, 2012

View Archived Issues

Novel agents for migraine prepared at Merck & Co.

Jenrin Discovery designs novel compounds targeting the cannabinoid CB1 receptor

Pilot study evaluates iobenguane (131I) in newly diagnosed high-risk neuroblastoma

Novel anticancer TLR7 agonists disclosed

New agents for pulmonary hypertension presented by Ironwood Pharmaceuticals

Celgene patents novel inhibitors of mutant EGFR

U.S. researchers disclose novel metalloenzyme inhibitors

New antisense oligonucleotides designed at Japanese university

Instituto Biomar reports new agents from a marine microorganism

Novel prognostic marker for cervical cancer correlates with EGFR expression

Gilead characterizes bifunctional LABA/PDE4 inhibitor

Data from expanded moxetumomab trial support further testing

Phase I/II trial evaluates KW-2871 combination therapy in melanoma

Newron announces acquisition plan

JDRF and Novo Nordisk establish type 1 diabetes partnership

Upsher-Smith to acquire European biotechnology company

FDA grants orphan drug status to new Regenicin product

Azaya Therapeutics reports phase I liposomal docetaxel data

EMA's COMP issues opinion on Enhoxy

Biofrontera to pursue U.S. registration of Ameluz

Ophthotech reports results from Fovista/Lucentis study

Janssen clear to take FGFR kinase inhibitor into phase I trials

Kuros reports promising results on novel dural sealant

New SBIR grant supports malaria research at Sanaria and IBBR

SymBio product gets Japanese orphan drug status for CLL

Shionogi reports initial data from S-555739 trial in allergic rhinitis

FDA accepts NDA for Raptor Pharmaceuticals' nephropathic cystinosis drug

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...